HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan Marik Selected Research

Autoantigens

5/2005Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.
5/2004Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan Marik Research Topics

Disease

27Neoplasms (Cancer)
01/2023 - 10/2004
4Breast Neoplasms (Breast Cancer)
01/2021 - 09/2007
4Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 05/2005
3Neoplasm Metastasis (Metastasis)
01/2021 - 11/2006
3Prostatic Neoplasms (Prostate Cancer)
05/2016 - 11/2006
3Lung Neoplasms (Lung Cancer)
09/2007 - 10/2004
2Alzheimer Disease (Alzheimer's Disease)
09/2023 - 09/2019
2Carcinoma (Carcinomatosis)
01/2016 - 08/2007
2Hypoxia (Hypoxemia)
09/2015 - 06/2009
2Lymphoma (Lymphomas)
09/2007 - 07/2006
2Adenocarcinoma
10/2005 - 05/2005
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
05/2005 - 05/2004
1Herpes Simplex
01/2020
1Amyloid Plaque
09/2019
1Brain Neoplasms (Brain Tumor)
08/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2017
1Mesothelioma
01/2017
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
09/2015
1Colonic Neoplasms (Colon Cancer)
07/2009
1Ischemia
06/2009
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2009
1Infarction (Infarctions)
06/2009
1Vascular Tissue Neoplasms
09/2007
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2007
1Inflammation (Inflammations)
08/2007
1Adenocarcinoma of Lung
06/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2006
1Glioblastoma (Glioblastoma Multiforme)
05/2005
1Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
10/2004

Drug/Important Bio-Agent (IBA)

9Peptides (Polypeptides)IBA
07/2011 - 10/2004
6LigandsIBA
01/2009 - 10/2004
5Cell Surface ReceptorsIBA
07/2009 - 05/2005
4Monoclonal AntibodiesIBA
01/2017 - 10/2005
4AntibodiesIBA
12/2013 - 05/2005
3Immunoconjugates (Immunoconjugate)IBA
03/2022 - 05/2016
3Radioisotopes (Radionuclides)IBA
01/2013 - 09/2007
3Integrin alpha3IBA
01/2009 - 05/2005
2(18F)GTP1IBA
09/2023 - 09/2019
2Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2019
2Indicators and Reagents (Reagents)IBA
01/2023 - 01/2023
2Trastuzumab (Herceptin)FDA Link
01/2021 - 08/2017
2Chelating AgentsIBA
01/2020 - 01/2016
2Deferoxamine (Desferal)FDA LinkGeneric
01/2020 - 01/2020
2Proteins (Proteins, Gene)FDA Link
09/2019 - 10/2009
2zirconium-89-trastuzumabIBA
08/2017 - 01/2016
2monomethyl auristatin EIBA
01/2017 - 05/2016
2integrin alphavbeta6IBA
07/2009 - 08/2007
2Cyclic PeptidesIBA
01/2009 - 10/2005
2PeptidomimeticsIBA
09/2007 - 07/2006
2Integrin alpha4beta1 (VLA-4)IBA
07/2006 - 10/2004
2AutoantigensIBA
05/2005 - 05/2004
2XenobioticsIBA
05/2005 - 05/2004
1serum P-component (CIt)IBA
01/2023
1Glycoproteins (Glycoprotein)IBA
01/2020
1Viral ProteinsIBA
01/2020
1benzyl isothiocyanateIBA
01/2020
1squaramideIBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
10/2019
1Monoamine Oxidase (MAO)IBA
09/2019
1tau Proteins (tau Protein)IBA
09/2019
1EnzymesIBA
08/2017
1Tryptophan (L-Tryptophan)FDA Link
08/2017
1Ado-Trastuzumab EmtansineIBA
08/2017
1KynurenineIBA
08/2017
1MesothelinIBA
01/2017
13-hydroxypyridin-2-oneIBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1Paclitaxel (Taxol)FDA LinkGeneric
01/2013
1PhosphatidylserinesIBA
01/2013
1Death Domain ReceptorsIBA
01/2013
1Proto-Oncogene Proteins c-metIBA
10/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011
1tanespimycin (17AAG)IBA
10/2009
1Deoxyglucose (2 Deoxy D glucose)IBA
07/2009
1Glial Fibrillary Acidic ProteinIBA
06/2009
1triphenyltetrazoliumIBA
06/2009
1Rituximab (Mabthera)FDA Link
09/2007
1BombesinIBA
09/2007
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
09/2007
1Peptide LibraryIBA
09/2007
1Peptide Hormones (Polypeptide Hormones)IBA
09/2007
1Amino AcidsFDA Link
11/2006
1Extracellular Matrix ProteinsIBA
11/2006
1ElementsIBA
11/2006
1lysyl- isoleucyl- lysyl- methionyl- valyl- isoleucyl- seryl- tryptophyl- lysyl- glycineIBA
11/2006
1Alanine (L-Alanine)FDA Link
11/2006
1Fluorescent Dyes (Fluorescent Probes)IBA
07/2006
1Integrin alpha3beta1IBA
06/2006
1StreptavidinIBA
10/2005
1Biotin (Vitamin H)FDA Link
10/2005
1CY5.5 cyanine dyeIBA
10/2005
12-octynoic acidIBA
05/2005
1Food Additives (Food Additive)IBA
05/2005
1IntegrinsIBA
05/2005

Therapy/Procedure

9Therapeutics
01/2023 - 07/2006
5Immunotherapy
01/2023 - 09/2007
1Castration
05/2016
1Ligation
06/2009
1Intravenous Injections
10/2005